| ²é¿´: 986 | »Ø¸´: 10 | |||
zhtear99Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
FDA³ÆPradaxaÔÚÖÎÁÆÖзçʱÒý·¢µÄ³öѪ·çÏÕÓëwarfarinµÄÏà²îÎÞ¼¸ ÒÑÓÐ4È˲ÎÓë
|
|
ÔÎÄÁ´½Ó£º http://medcitynews.com/2012/11/f ... arin/#ixzz2BEwbN7pM The risk of serious bleeding among new users of Pradaxa, a blood-clot preventer made by Germany's BoehringerIngelheim, appeared to be no higher than in patients on the widely used standard blood thinner warfarin, U.S. regulators said. ÃÀ¹ú¼à²ìÔ±Ö¸³ö£¬Óɵ¹úBoehringerIngelheim¹«Ë¾Ñз¢µÄѪ¿éÔ¤·ÀÒ©ÎïPradaxaÒý·¢µÄÑÏÖØ³öѪ·çÏÕ£¬Óë±»¹ã·ºÓ¦ÓõÄѪҺϡÊͼÁwarfarinµÄ£¨ÖÎÁÆ·çÏÕ£©ÊDz¶àµÄ¡£ The announcement Friday by the U.S. Food and Drug Administration may allay some safety concerns about Pradaxa, a pill developed by the privately held drugmakerBoehringer, to prevent strokes among patients with an irregular heartbeat known as atrial fibrillation. ÖÜÎåµÄͨ¸æ±íÃ÷£¬FDA¿ÉÄÜ»á¼õÉÙ¶ÔPradaxa°²È«ÐÔÎÊÌâµÄ¹Ø×¢¡£PradaxaÊÇÓÉBoehringer¹«Ë¾¶À¼ÒÑз¢µÄ¿ÉÔ¤·ÀÐÄ·¿²ü¶¯£¨ÐÄÂÉʧ³££©²¡ÈËÖзçµÄÒ©Îï¡£ The regulator's findings were based on an assessment of insurance claims and other data. Over the past year, the FDA has been analyzing reports of serious bleeding among patients prescribed Pradaxa, including gastrointestinal bleeding and bleeding in the brain. ¼à²ìÔ±µÄÕâЩ·¢ÏÖÊÇͨ¹ý¶ÔһЩ±£ÏÕË÷ÅâµÄ°¸ÀýºÍÆäËüһЩÊý¾Ý½øÐÐÆÀ¹ÀµÃµ½µÄ¡£ÔÚ¹ýÈ¥µÄÒ»ÄêÀFDA£¨¼à²ìÔ±£©ÒѾ·ÖÎöÁ˲¡ÈËÒòPradaxaÖÎÁÆÒý·¢ÑÏÖØ³öѪµÄ±¨¸æ£¬°üÀ¨Î¸³¦µÀ³öѪºÍÄÔ³öѪ¡£ The agency said on Friday a comparable risk of serious bleeding for Pradaxa and warfarin was suggested by its review of insurance claims and by analyzing electronic healthcare data from multiple other sources. ͨ¹ý·ÖÎö±£ÏÕË÷Åâ°¸ÀýºÍÔ´ÓÚ¶à¸öÇþµÀµÄµç×ÓÒ½ÁÆÊý¾Ý£¬FDAÓÚÖÜÎåÖ¸³öPradaxaºÍwarfarin£¨ÖÎÁÆÖзçʱ£©¿ÉÄÜÒý·¢µÄÑÏÖØ³öѪ·çÏÕÊÇÏà½üµÄ¡£ The FDA said it was also planning other assessments of Pradaxa's bleeding risks. Õë¶ÔPradaxa£¨ÖÎÁÆÖз磩Òý·¢µÄ³öѪ·çÏÕ£¬FDAÉù³Æ»á¿¼ÂÇһЩÆäËûµÄÆÀ¹À·½°¸¡£ The medicine competes with Xarelto, a stroke-prevention pill for atrial fibrillation patients developed by Johnson & Johnson and Bayer AG. A similar pill being developed by Bristol-Myers Squibb and Pfizer Inc, Eliquis, is awaiting U.S. approval and is deemed by many Wall Street analysts to be the most impressive of a new generation of oral drugs to replace warfarin. Pradaxa¿ÉÓëXareltoÏàæÇÃÀ£¬¶øºóÕßÊÇÓÉJohnson & JohnsonºÍBayer AG¹«Ë¾ÁªºÏÑз¢µÄÒ»ÖÖ¿ÉÓÃÓÚÔ¤·ÀÐÄ·¿²ü¶¯²¡ÈËÖзçµÄÒ©Îï¡£ÓÉBristol-Myers Squibb and Pfizer¹«Ë¾Ñз¢µÄEliquisÒ²ÊÇÒ»ÖÖÔ¤·ÀÖзçµÄÒ©ÎĿǰ¸ÃÒ©ÕýÔڵȴýFDAµÄÉóÅú¡£ÃÀ¹ú»ª¶û½Ö·ÖÎöÔ±ÈÏΪEliquisÔÚÈ¡´úwarfarinµÄÐÂÒ»´ú¿Ú·þÒ©ÎïÖÐ×îÁîÈËÖõÄ¿¡£ P.S.£º¸Ðлokitworks~ ˮƽÓÐÏÞ£¬»¶Ó´ó¼Ò¾À´í£¬Ò»Æð½»Á÷£¬»¥Ïàѧϰ~ [ Last edited by zhtear99 on 2012-11-5 at 08:09 ] |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ3È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼ÓÖдÓʼþÁË£¬Ã»»Ø¸´
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧ˶318Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
081700»¯¹¤Ñ§Ë¶µ÷¼Á
ÒѾÓÐ3È˻ظ´

ÁèÓîÀ׳Ø
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
Сľ³æ¿ÆÑдóʹ\(^o^)/~
- Ó¦Öú: 758 (²©ºó)
- ¹ó±ö: 161.796
- ½ð±Ò: 301076
- É¢½ð: 91930
- ºì»¨: 1119
- ɳ·¢: 3434
- Ìû×Ó: 93041
- ÔÚÏß: 54895.6Сʱ
- ³æºÅ: 659100
- ×¢²á: 2008-11-21
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ
- ¹ÜϽ: ¿ÆÑÐÉú»îÇø

2Â¥2012-11-05 08:04:28
zhtear99
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- SFL-EPI: 1
- Ó¦Öú: 147 (¸ßÖÐÉú)
- ¹ó±ö: 0.662
- ½ð±Ò: 3343.9
- É¢½ð: 5190
- ºì»¨: 53
- ɳ·¢: 4
- Ìû×Ó: 1869
- ÔÚÏß: 714.6Сʱ
- ³æºÅ: 1001108
- ×¢²á: 2010-04-19
- ÐÔ±ð: MM
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ

3Â¥2012-11-05 08:12:33
ÁèÓîÀ׳Ø
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
Сľ³æ¿ÆÑдóʹ\(^o^)/~
- Ó¦Öú: 758 (²©ºó)
- ¹ó±ö: 161.796
- ½ð±Ò: 301076
- É¢½ð: 91930
- ºì»¨: 1119
- ɳ·¢: 3434
- Ìû×Ó: 93041
- ÔÚÏß: 54895.6Сʱ
- ³æºÅ: 659100
- ×¢²á: 2008-11-21
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ
- ¹ÜϽ: ¿ÆÑÐÉú»îÇø

4Â¥2012-11-05 08:24:03
¹Å¿É¤×
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 91 (³õÖÐÉú)
- ¹ó±ö: 16.835
- ½ð±Ò: 19237.1
- É¢½ð: 40372
- ºì»¨: 275
- ɳ·¢: 183
- Ìû×Ó: 25406
- ÔÚÏß: 1082.3Сʱ
- ³æºÅ: 1034379
- ×¢²á: 2010-06-02
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
- ¹ÜϽ: µ¼Ê¦ÕÐÉú
|
²»´í¡Ð¡ÓãÀ÷º¦¡¼ÌÐø¡£Ã¨½ã×Ô¼º±¾À´±ÈÕÔÇø»¹Ð¡Æø¡ÎÒ·¢ÁËÁ½Æª¶¼ÊÇÁ½¸ö¡ÕÔÇø¸øÎå¸öÊÇÄãµÄÁ½±¶°ë¡»¹ºÃÒâ˼¶ßà¡ßã¹þ¹þ¡´þס»ú»áÄñ¡¼ÇµÃ¸øÐ¡Óã²¹¸öepi@ringzhu [ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ] [ Last edited by ¹Å¿É¤× on 2012-11-5 at 23:10 ] |

5Â¥2012-11-05 23:08:50
zhtear99
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- SFL-EPI: 1
- Ó¦Öú: 147 (¸ßÖÐÉú)
- ¹ó±ö: 0.662
- ½ð±Ò: 3343.9
- É¢½ð: 5190
- ºì»¨: 53
- ɳ·¢: 4
- Ìû×Ó: 1869
- ÔÚÏß: 714.6Сʱ
- ³æºÅ: 1001108
- ×¢²á: 2010-04-19
- ÐÔ±ð: MM
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ

6Â¥2012-11-05 23:54:11
myIDname
ľ³æ (ÖøÃûдÊÖ)
ÈËÃñ´ó»áÌÃÊ×ϯÇå½à¹¤
- SFL-EPI: 17
- Ó¦Öú: 143 (¸ßÖÐÉú)
- ¹ó±ö: 0.295
- ½ð±Ò: 1700.4
- É¢½ð: 1020
- ºì»¨: 30
- ɳ·¢: 2
- Ìû×Ó: 2540
- ÔÚÏß: 414.7Сʱ
- ³æºÅ: 1586017
- ×¢²á: 2012-01-24
- רҵ: ΢/ÄÉ»úеϵͳ
ËÍÏÊ»¨Ò»¶ä |
ÔÞÒ»¸ö£¡ ¶¼·Ç³£ºÃ£¡¾Í˵һ¸ö£¬¹ØÓÚinsurance claim£¬ÄÜ·ñ·Òë³ÉË÷¿î£¨ÌýÆðÀ´¹Ö¹ÖµÄ£¬ºÇºÇ£©¡£ÎҲ鵽µÄÒ»¸ö½âÊÍÊÇA formal request to an insurance company asking for a payment based on the terms of the insurance policy.¸Ð¾õ·³É¡°Ë÷Å⡱µÄ»°£¬ºÃÏñ°µÊ¾ÒòΪʹʻòÕßijÖÖÒâÍâÒýÆðµÄ¾¼ÃÅâ³¥£¬ÆäʵËü½ö½öÊÇÒ»¸öÕý³£µÄÁ÷³Ì¡£ ¾ÍÎÒ¸öÈ˾Àú¶øÑÔ£¬ÏÈÒ½Ôº¿´²¡£¬È»ºóÒ½Ôº»á¸øÒ½ÁƱ£ÏÕ¹«Ë¾·¢È¥claim£¬¾Í˵ÎÒ×ܹ²»¨Á˶àÉÙÇ®£¬ÒªÇó±£ÏÕ¹«Ë¾¸¶¸øÒ½ÔºËûÃǸø¶µÄÄDz¿·Ö£¬È»ºóÒ½Ôº»ØÍ·ÔÙÎÊÎÒҪʣϵÄÎҸø¶µÄÄDz¿·Ö¡£ ÎÒ²»ÖªµÀ¹úÄÚÒ½ÁƱ£ÏÕʲô³ÌÐò£¬¸Ð¾õÕâ¸öclaimºÜÄѶÔÓ¦Ò»¸öÖÐÎÄ´ÊÀ´ÃèÊöËü£¬µÈ´ý¸ßÊÖ¡£¡£¡£ |

7Â¥2012-11-06 02:54:00
zhtear99
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- SFL-EPI: 1
- Ó¦Öú: 147 (¸ßÖÐÉú)
- ¹ó±ö: 0.662
- ½ð±Ò: 3343.9
- É¢½ð: 5190
- ºì»¨: 53
- ɳ·¢: 4
- Ìû×Ó: 1869
- ÔÚÏß: 714.6Сʱ
- ³æºÅ: 1001108
- ×¢²á: 2010-04-19
- ÐÔ±ð: MM
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ

8Â¥2012-11-06 08:22:55
ringzhu
ľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ¹ó±ö: 1.318
- ½ð±Ò: 1370.6
- É¢½ð: 8739
- ºì»¨: 60
- ɳ·¢: 11
- Ìû×Ó: 4511
- ÔÚÏß: 703.5Сʱ
- ³æºÅ: 825134
- ×¢²á: 2009-08-10
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ
9Â¥2012-11-06 10:11:10
ringzhu
ľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ¹ó±ö: 1.318
- ½ð±Ò: 1370.6
- É¢½ð: 8739
- ºì»¨: 60
- ɳ·¢: 11
- Ìû×Ó: 4511
- ÔÚÏß: 703.5Сʱ
- ³æºÅ: 825134
- ×¢²á: 2009-08-10
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ
10Â¥2012-11-06 10:11:59













»Ø¸´´ËÂ¥
ÎÒµ±Ê±¶ÔÕâ¸ö´Êû¶à¼Ó¿¼ÂÇ£¬»¹ÊÇÄã±È½ÏÈÏÕæ£¬¸ú×ÅÄãѧϰÀ²~~